Julia Baguña Torres1, Erica M Andreozzi1, Joel T Dunn1, Muhammad Siddique1, Istvan Szanda1, David R Howlett2, Kavitha Sunassee1, Philip J Blower3. 1. King's College London, Division of Imaging Sciences and Biomedical Engineering, St. Thomas' Hospital, London, United Kingdom; and. 2. King's College London, Wolfson Centre for Age-Related Diseases, London, United Kingdom. 3. King's College London, Division of Imaging Sciences and Biomedical Engineering, St. Thomas' Hospital, London, United Kingdom; and philip.blower@kcl.ac.uk.
Abstract
UNLABELLED: Alzheimer disease (AD) is a fatal neurodegenerative disorder characterized by progressive neuronal loss and cognitive decline. The lack of reliable and objective diagnostic markers for AD hampers early disease detection and treatment. Growing evidence supports the existence of a dysregulation in brain copper trafficking in AD. The aim of this study was to investigate brain copper trafficking in a transgenic mouse model of AD by PET imaging with (64)Cu, to determine its potential as a diagnostic biomarker of the disorder. METHODS: Brain copper trafficking was evaluated in 6- to 8-mo-old TASTPM transgenic mice and age-matched wild-type controls using the (64)Cu bis(thiosemicarbazone) complex (64)Cu-GTSM (glyoxalbis(N(4)-methyl-3-thiosemicarbazonato) copper(II)), which crosses the blood-brain barrier and releases (64)Cu bioreductively into cells. Animals were intravenously injected with (64)Cu-GTSM and imaged at 0-30 min and 24-25 h after injection. The images were analyzed by atlas-based quantification and texture analysis. Regional distribution of (64)Cu in the brain 24 h after injection was also evaluated via ex vivo autoradiography and compared with amyloid-β plaque deposition in TASTPM mice. RESULTS: Compared with controls, in TASTPM mice PET image analysis demonstrated significantly increased (by a factor of ~1.3) brain concentration of (64)Cu at 30 min (P < 0.01) and 24 h (P < 0.05) after injection of the tracer and faster (by a factor of ~5) (64)Cu clearance from the brain (P < 0.01). Atlas-based quantification and texture analysis revealed significant differences in regional brain uptake of (64)Cu and PET image heterogeneity between the 2 groups of mice. Ex vivo autoradiography showed that regional brain distribution of (64)Cu at 24 h after injection did not correlate with amyloid-β plaque distribution in TASTPM mice. CONCLUSION: The trafficking of (64)Cu in the brain after administration of (64)Cu-GTSM is significantly altered by AD-like pathology in the TASTPM mouse model, suggesting that (64)Cu-GTSM PET imaging warrants clinical evaluation as a diagnostic tool for AD and possibly other neurodegenerative disorders.
UNLABELLED: Alzheimer disease (AD) is a fatal neurodegenerative disorder characterized by progressive neuronal loss and cognitive decline. The lack of reliable and objective diagnostic markers for AD hampers early disease detection and treatment. Growing evidence supports the existence of a dysregulation in brain copper trafficking in AD. The aim of this study was to investigate brain copper trafficking in a transgenic mouse model of AD by PET imaging with (64)Cu, to determine its potential as a diagnostic biomarker of the disorder. METHODS: Brain copper trafficking was evaluated in 6- to 8-mo-old TASTPM transgenic mice and age-matched wild-type controls using the (64)Cu bis(thiosemicarbazone) complex (64)Cu-GTSM (glyoxalbis(N(4)-methyl-3-thiosemicarbazonato) copper(II)), which crosses the blood-brain barrier and releases (64)Cu bioreductively into cells. Animals were intravenously injected with (64)Cu-GTSM and imaged at 0-30 min and 24-25 h after injection. The images were analyzed by atlas-based quantification and texture analysis. Regional distribution of (64)Cu in the brain 24 h after injection was also evaluated via ex vivo autoradiography and compared with amyloid-β plaque deposition in TASTPM mice. RESULTS: Compared with controls, in TASTPM mice PET image analysis demonstrated significantly increased (by a factor of ~1.3) brain concentration of (64)Cu at 30 min (P < 0.01) and 24 h (P < 0.05) after injection of the tracer and faster (by a factor of ~5) (64)Cu clearance from the brain (P < 0.01). Atlas-based quantification and texture analysis revealed significant differences in regional brain uptake of (64)Cu and PET image heterogeneity between the 2 groups of mice. Ex vivo autoradiography showed that regional brain distribution of (64)Cu at 24 h after injection did not correlate with amyloid-β plaque distribution in TASTPM mice. CONCLUSION: The trafficking of (64)Cu in the brain after administration of (64)Cu-GTSM is significantly altered by AD-like pathology in the TASTPM mouse model, suggesting that (64)Cu-GTSM PET imaging warrants clinical evaluation as a diagnostic tool for AD and possibly other neurodegenerative disorders.
Authors: Istvan Szanda; Jane Mackewn; Gergely Patay; Peter Major; Kavitha Sunassee; Gregory E Mullen; Gabor Nemeth; York Haemisch; Philip J Blower; Paul K Marsden Journal: J Nucl Med Date: 2011-10-03 Impact factor: 10.057
Authors: Anthony R White; Tai Du; Katrina M Laughton; Irene Volitakis; Robyn A Sharples; Michel E Xilinas; David E Hoke; R M Damian Holsinger; Geneviève Evin; Robert A Cherny; Andrew F Hill; Kevin J Barnham; Qiao-Xin Li; Ashley I Bush; Colin L Masters Journal: J Biol Chem Date: 2006-04-28 Impact factor: 5.157
Authors: David P Smith; Danielle G Smith; Cyril C Curtain; John F Boas; John R Pilbrow; Giuseppe D Ciccotosto; Tong-Lay Lau; Deborah J Tew; Keyla Perez; John D Wade; Ashley I Bush; Simon C Drew; Frances Separovic; Colin L Masters; Roberto Cappai; Kevin J Barnham Journal: J Biol Chem Date: 2006-04-04 Impact factor: 5.157
Authors: Noel G Faux; Craig W Ritchie; Adam Gunn; Alan Rembach; Andrew Tsatsanis; Justin Bedo; John Harrison; Lars Lannfelt; Kaj Blennow; Henrik Zetterberg; Martin Ingelsson; Colin L Masters; Rudolph E Tanzi; Jeffrey L Cummings; Caroline M Herd; Ashley I Bush Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472
Authors: Gary J R Cook; Connie Yip; Muhammad Siddique; Vicky Goh; Sugama Chicklore; Arunabha Roy; Paul Marsden; Shahreen Ahmad; David Landau Journal: J Nucl Med Date: 2012-11-30 Impact factor: 10.057
Authors: David R Howlett; Jill C Richardson; Angela Austin; Andrew A Parsons; Simon T Bate; D Ceri Davies; M Isabel Gonzalez Journal: Brain Res Date: 2004-08-13 Impact factor: 3.252
Authors: Peter J Crouch; Lin Wai Hung; Paul A Adlard; Mikhalina Cortes; Varsha Lal; Gulay Filiz; Keyla A Perez; Milawaty Nurjono; Aphrodite Caragounis; Tai Du; Katrina Laughton; Irene Volitakis; Ashley I Bush; Qiao-Xin Li; Colin L Masters; Roberto Cappai; Robert A Cherny; Paul S Donnelly; Anthony R White; Kevin J Barnham Journal: Proc Natl Acad Sci U S A Date: 2009-01-02 Impact factor: 11.205
Authors: Paul T Bremer; Sabine Pellett; James P Carolan; William H Tepp; Lisa M Eubanks; Karen N Allen; Eric A Johnson; Kim D Janda Journal: J Am Chem Soc Date: 2017-05-19 Impact factor: 15.419
Authors: Erica M Andreozzi; Julia Baguña Torres; Kavitha Sunassee; Joel Dunn; Simon Walker-Samuel; Istvan Szanda; Philip J Blower Journal: Metallomics Date: 2017-11-15 Impact factor: 4.526
Authors: Mikko T Huuskonen; Qing-Zhang Tuo; Sanna Loppi; Hiramani Dhungana; Paula Korhonen; Lachlan E McInnes; Paul S Donnelly; Alexandra Grubman; Sara Wojciechowski; Katarina Lejavova; Yuriy Pomeshchik; Laura Periviita; Lotta Kosonen; Martina Giordano; Frederick R Walker; Rong Liu; Ashley I Bush; Jari Koistinaho; Tarja Malm; Anthony R White; Peng Lei; Katja M Kanninen Journal: Neurotherapeutics Date: 2017-04 Impact factor: 7.620
Authors: Marie C Heffern; Hyo Min Park; Ho Yu Au-Yeung; Genevieve C Van de Bittner; Cheri M Ackerman; Andreas Stahl; Christopher J Chang Journal: Proc Natl Acad Sci U S A Date: 2016-11-29 Impact factor: 11.205
Authors: Eva J Ge; Ashley I Bush; Angela Casini; Paul A Cobine; Justin R Cross; Gina M DeNicola; Q Ping Dou; Katherine J Franz; Vishal M Gohil; Sanjeev Gupta; Stephen G Kaler; Svetlana Lutsenko; Vivek Mittal; Michael J Petris; Roman Polishchuk; Martina Ralle; Michael L Schilsky; Nicholas K Tonks; Linda T Vahdat; Linda Van Aelst; Dan Xi; Peng Yuan; Donita C Brady; Christopher J Chang Journal: Nat Rev Cancer Date: 2021-11-11 Impact factor: 69.800
Authors: Timothy A Su; Diyala S Shihadih; Wendy Cao; Tyler C Detomasi; Marie C Heffern; Shang Jia; Andreas Stahl; Christopher J Chang Journal: J Am Chem Soc Date: 2018-10-15 Impact factor: 16.383
Authors: Andrea J North; John A Karas; Michelle T Ma; Philip J Blower; Uwe Ackermann; Jonathan M White; Paul S Donnelly Journal: Inorg Chem Date: 2017-08-02 Impact factor: 5.165